» Articles » PMID: 38178928

Exosomal MicroRNA-Based Therapies for Skin Diseases

Overview
Journal Regen Ther
Date 2024 Jan 5
PMID 38178928
Authors
Affiliations
Soon will be listed here.
Abstract

Based on engineered cell/exosome technology and various skin-related animal models, exosomal microRNA (miRNA)-based therapies derived from natural exosomes have shown good therapeutic effects on nine skin diseases, including full-thickness skin defects, diabetic ulcers, skin burns, hypertrophic scars, psoriasis, systemic sclerosis, atopic dermatitis, skin aging, and hair loss. Comparative experimental research showed that the therapeutic effect of miRNA-overexpressing exosomes was better than that of their natural exosomes. Using a dual-luciferase reporter assay, the targets of all therapeutic miRNAs in skin cells have been screened and confirmed. For these nine types of skin diseases, a total of 11 animal models and 21 exosomal miRNA-based therapies have been developed. This review provides a detailed description of the animal models, miRNA therapies, disease evaluation indicators, and treatment results of exosomal miRNA therapies, with the aim of providing a reference and guidance for future clinical trials. There is currently no literature on the merits or drawbacks of miRNA therapies compared with standard treatments.

Citing Articles

Effectiveness of Extracellular Vesicle Application in Skin Aging Treatment and Regeneration: Do We Have Enough Evidence from Clinical Trials?.

Domaszewska-Szostek A, Krzyzanowska M, Polak A, Puzianowska-Kuznicka M Int J Mol Sci. 2025; 26(5).

PMID: 40076975 PMC: 11899913. DOI: 10.3390/ijms26052354.

References
1.
Li P, Hong G, Zhan W, Deng M, Tu C, Wei J . Endothelial progenitor cell derived exosomes mediated miR-182-5p delivery accelerate diabetic wound healing via down-regulating PPARG. Int J Med Sci. 2023; 20(4):468-481. PMC: 10087624. DOI: 10.7150/ijms.78790. View

2.
Huayllani M, Sarabia-Estrada R, Restrepo D, Boczar D, Sisti A, Nguyen J . Adipose-derived stem cells in wound healing of full-thickness skin defects: a review of the literature. J Plast Surg Hand Surg. 2020; 54(5):263-279. DOI: 10.1080/2000656X.2020.1767116. View

3.
Khanna R, Khanna R, Desai S . Diagnosing Psoriasis in Skin of Color Patients. Dermatol Clin. 2023; 41(3):431-434. DOI: 10.1016/j.det.2023.02.002. View

4.
Gao S, Chen T, Hao Y, Zhang F, Tang X, Wang D . Exosomal miR-135a derived from human amnion mesenchymal stem cells promotes cutaneous wound healing in rats and fibroblast migration by directly inhibiting LATS2 expression. Stem Cell Res Ther. 2020; 11(1):56. PMC: 7020560. DOI: 10.1186/s13287-020-1570-9. View

5.
Baral H, Uchiyama A, Yokoyama Y, Sekiguchi A, Yamazaki S, Amalia S . Antifibrotic effects and mechanisms of mesenchymal stem cell-derived exosomes in a systemic sclerosis mouse model: Possible contribution of miR-196b-5p. J Dermatol Sci. 2021; 104(1):39-47. DOI: 10.1016/j.jdermsci.2021.08.006. View